Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry

Thrombosis Research

Volumn 126, Issue 4, 2010, Pages 283-286

  Gadelha, Telma ^a   Roldán, Vanessa ^b   Lecumberri, Ramón ^c   Trujillo Santos, Javier ^d   Del Campo, Raquel ^e   Poggio, Renzo ^f   Monreal, Manuel ^g  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF MURCIA   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d Hospital Universitario Santa Maria del Rosell   (Spain)

^e HOSPITAL SON LLÀTZER   (Spain)

^f GALLIERA HOSPITAL   (Italy)

^g HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Asymptomatic carriers; Factor V Leiden; Prothrombin G20210A; Thrombophilia; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5; PROTHROMBIN;

ADULT; ARTICLE; CLINICAL FEATURE; CONTRACEPTION; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; HUMAN; HYPOXEMIA; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; FACTOR V; FEMALE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; PROTHROMBIN; RISK FACTORS; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 77957115664     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.06.019     Document Type: Article

References (25)

1. O. Wu, L. Robertson, S. Twaddle, G. Lowe, P. Clark, and M. Greaves Screening for thrombophilia in high-risk situations: Systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study Health Technol Assess 10 2006 1 110
2. J.A. Heit Thrombophilia: Common questions on laboratory assessment and management Hematology Am Soc Hematol Educ Program 2007 2007 127 135
3. O. Wu, and I.A. Greer Is screening for thrombophilia cost-effective? Curr Opin Hematol 14 2007 500 503
4. I. Martinelli, P.M. Mannucci, V. De Stefano, E. Taioli, V. Rossi, and F. Crosti Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families Blood 92 1998 2353 2358
5. I. Martinelli Pros and cons of thrombophilia testing: pros J Thromb Haemost 1 2003 410 411
6. P.G. Lindqvist, and B. Dahlback Reactions to awareness of activated protein C resistance carriership: a descriptive study of 270 women Acta Obstet Gynecol Scand 82 2003 467 470
7. E.A. Hellmann, N.D. Leslie, and S. Moll Knowledge and educational needs of individuals with the factor V Leiden mutation J Thromb Haemost 1 2003 2335 2339
8. I.M. Van Korlaar, C.Y. Vossen, F.R. Rosendaal, E.G. Bovill, S. Naud, and L.D. Cameron Attitudes toward genetic testing for thrombophilia in asymptomatic members of a large family with heritable protein C deficiency J Thromb Haemost 3 2005 2437 2444
9. V. Gartner, M. Weber, and S. Eichinger The emotional impact of genetic testing and aspects of counseling prior to prescription of oral contraceptives Contraception 78 2008 392 398
10. D.M. Cohn, F. Vansenne, A.A. Kaptein, C.A.J.M. de Borgie, and S. Middeldorp The psychological impact of testing for thrombophilia: a systematic review J Thromb Haemost 6 2008 1099 1104
11. N. Ruíz-Giménez, C. Suárez, R. González, J.A. Nieto, A. Todolí, and L.A. Sampériz RIETE Investigators. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry Thromb Haemost 100 2008 26 31
12. A. Blanco-Molina, L. Rota, P. Di Micco, B. Brenner, J. Trujillo-Santos, and A. Ruíz-Gamietea RIETE investigators. Venous thromboembolism during pregnancy, postpartum or contraceptive use. Findings from the RIETE Registry Thromb Haemost 103 2010 306 311
13. V. Roldán, R. Lecumberri, J.F. Sánchez Muñoz-Torrero, V. Vicente, E. Rocha, and B. Brenner RIETE Investigators. Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE Registry Thromb Res 124 2009 174 177
14. U. Seligsohn, and A. Lubetsky Genetic susceptibility to venous thrombosis N Engl J Med 344 16 2001 1222 1231
15. I. Martinelli, T. Battaglioni, C. Razzari, and P.M. Mannucci Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia J Thromb Haemost 5 2006 98 101
16. T.P. Baglin, K. Brown, D. Willamson, P. Baker, and R. Luddington Relative risk of pulmonary embolism and deep vein thrombosis in association with the factor V Leiden in a United Kingdom population Thromb Haemost 77 1997 1219
17. M. Margaglione, V. Brancaccio, D. De Lucia, I. Martinelli, A. Ciampa, and E. Grandone Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism Chest 118 2000 1405 1411
18. G. Meyer, J. Emmerich, D. Helley, E. Arnaud, V. Nicaud, and M. Alhenc-Gelas Factors V Leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis Am J Med 110 2001 12 15
19. E. Rossi, T. Za, A. Ciminello, G. Leone, and V. De Stefano The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia Thromb Haemost 99 2008 1030 1034
20. D. Aujesky, R. Hughes, and D. Jiménez Short-term prognosis of pulmonary embolism J Thromb Haemost 7 Suppl 1 2009 318 321
21. W.M. Lijfering, J.L.P. Brouwer, N.J.G.M. Veeger, I. Bank, M. Coppens, and S. Middeldorp Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives Blood 113 2009 5314 5322
22. H. Heijboer, D.P. Brandjes, H.R. Büller, A. Sturk, and J.W. ten Cate Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep vein thrombosis N Engl J Med 323 1990 1512 1516
23. A.S. Awidi, M. Abu-Khalaf, U. Herzallah, A. Abu-Rajab, M.M. Shannak, and T. Abu-Obeid Hereditary thrombophilia among 217 consecutive patients with thromboembolic disease in Jordan Am J Hematol 44 1993 95 100
24. M.D. Tabernero, J.F. Tomas, I. Alberca, A. Orfao, A. Lopez-Borrasca, and V. Vicente Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis Am J Hematol 36 1991 249 254
25. A. Marchiori, L. Mosena, M.H. Prins, and P. Prandoni The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies Haematologica 92 2007 1107 1114